Predicate |
Object |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-04 |
filingDate |
2002-11-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2005-05-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2005514348-A |
titleOfInvention |
Peptides aiming at tumor lymphatic vasculature and methods of use thereof |
abstract |
The present invention provides a conjugate comprising a moiety linked to a homing molecule that selectively targets tumor lymphoid vasculature. The present invention also relates to tumor lymphatic vasculature in a subject by administering to the subject a conjugate comprising a moiety linked to a homing molecule that selectively targets the tumor lymphatic vasculature. Provide a way to direct the part. The conjugate is, for example, an isolated peptide or peptidomimetic, the isolated peptide or peptidomimetic comprising the amino acid sequence GNKRTRG (SEQ ID NO: 2) or a peptidomimetic thereof. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009525055-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2016522205-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013525285-A |
priorityDate |
2001-11-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |